Bethesda, MD, United States of America

Ji-Young Min

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Institut Pasteur Korea, Seoul National University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ji-Young Min. Retrieved from https://idiyas.com/inventor/ji-young-min-p8egnsdc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ji-Young Min

Introduction

Ji-Young Min is a prominent inventor based in Bethesda, MD, known for her significant contributions to the field of medical research. With a focus on infectious diseases, she has developed innovative solutions that aim to improve diagnosis and treatment methods.

Latest Patents

Ji-Young Min holds a patent for an antibody that binds to the envelope glycoprotein of the severe fever with thrombocytopenia syndrome virus (SFTSV). This invention is crucial for effectively detecting and diagnosing SFTSV, which is the pathogen responsible for severe fever with thrombocytopenia syndrome (SFTS). The antibody developed by Min plays a vital role in the treatment of this serious illness.

Career Highlights

Throughout her career, Ji-Young Min has worked with esteemed institutions such as Seoul National University and Institut Pasteur Korea. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Junho Chung and Ki-Hyun Kim, who have also made significant contributions to the field of medical research. Their collaborative efforts have further advanced the understanding and treatment of infectious diseases.

Conclusion

Ji-Young Min's innovative work and dedication to medical research have made her a valuable contributor to the scientific community. Her patent for the antibody targeting SFTSV exemplifies her commitment to improving health outcomes through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…